Retour à la liste

Significance of observational data on type 2 diabetes management in North Africa

Aissa Boudiba

Diabetes Research and Clinical Practice, pages S1 - S3

Published online août-2013


Voir l'article:

References

Label Authors Title Source Year
1
PN Papanikolaou, GD Christidi, JPA Ioannidis Comparison of evidence on harms of medical interventions in randomized and nonrandomized studies CMAJ. 2006;174(5):635-641 2006
2
DR Whiting, L Guariguata, C Weil, J Shaw IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030 Diabetes Res Clin Pract. 2011;94(3):311-321 2011
3
International Diabetes Federation. IDF Diabetes Atlas. 5th ed. Brussels, Belgium; 2011, updated 14 November 2012.
4
International Diabetes Federation Middle East and North Africa region http://www.idf.org/sites/default/files/attachments/IDF-MENA-Action-Plan-141009.pdf (18 April 2009) 18 April 2009
5
P Home, NE Naggar, M Khamseh, G Gonzalez-Galvez, C Shen, P Chakkarwar, et al. An observational non-interventional study of patients with diabetes beginning or changed to insulin analogue therapy in non-Western countries: The A1chieve study Diabetes Res Clin Pract. 2011;94:352-363 2011
6
SE Inzucchi, RM Bergenstal, JB Buse, M Diamant, E Ferrannini, M Nauck, et al. Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) Diabetologia. 2012;55(6):1577-1596 2012
7
K Niswender Early and aggressive initiation of insulin therapy for type 2 diabetes: What is the evidence? Clin Diab. 2009;27:60-68 2009

Retour à la liste